Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bumi Resources Tbk (BUMI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Bumi Resources TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bumi Resources Tbk dan Brigit Biofarmaka Teknologi Tbk.: Bumi Resources Tbk diperdagangkan di Rp178 (kapitalisasi pasar 68,7 T, volume 24 jam 2,18 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Bumi Resources Tbk jauh lebih besar — sekitar 417,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Bumi Resources Tbk lebih aktif diperdagangkan (2,18 M vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.

BUMIOBAT
Kapitalisasi Pasar
68,7 T164,65 M
Volume
2,18 M187,4 rb
Lot
21,83 jt1,87 rb
Perputaran
395,66 M44,35 jt
Harga Rata-rata
181,27236,67
Nilai Transaksi
395,66 M44,35 jt
Harga Ekuilibrium Indikatif
178242
Volume Ekuilibrium Indikatif
784,9 rb500

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BUMI
Lihat detail
OBAT
Lihat detail

Tentang Bumi Resources Tbk

PT Bumi Resources Tbk was established in the Republic of Indonesia on June 26, 1973 based on Notarial Deed No. 130 and No. 103 dated Novmeber 28, 1973, both made by Djoko Soepadmo, S.H., notary in Surabaya. PT. Bumi Resources Tbk, previously named PT. Bumi Modern Tbk. (Company) is a Domestic Investment Company (PMDN), initially engaged in hotel and tourism industry. The Company has carried out diversification of activities expected to improve optimal return for shareholders. The Company deems it necessary to change the previous business activities, namely Hotel and Tourism Industries to Oil and Natural Gas Mining Industries.

Selengkapnya di halaman BUMI

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT